Literature DB >> 22132355

Mild cognitive impairment: diagnosis and treatment dilemmas.

Anna D Burke1, Roy Yaari, Adam S Fleisher, Helle Brand, Jan Dougherty, James D Seward, Pierre N Tariot.   

Abstract

Entities:  

Year:  2011        PMID： 22132355      PMCID： PMC3219518          DOI： 10.4088/PCC.11alz01241

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  16 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 3.  Memantine for dementia.

Authors:  R McShane; A Areosa Sastre; N Minakaran
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

4.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

5.  Prevalence of primitive reflexes and Parkinsonian signs in dementia.

Authors:  K A Links; D Merims; M A Binns; M Freedman; T W Chow
Journal:  Can J Neurol Sci       Date:  2010-09       Impact factor: 2.104

6.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

7.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

8.  Memantine discontinuation and the health status of nursing home residents with Alzheimer's disease.

Authors:  Howard Fillit; Robert K Hofbauer; Juliana Setyawan; Stavros Tourkodimitris; Moshe Fridman; Vojislav Pejović; Michael L Miller; M Haim Erder; Constantine Lyketsos
Journal:  J Am Med Dir Assoc       Date:  2010-08-21       Impact factor: 4.669

9.  Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.

Authors:  Howard H Feldman; Steven Ferris; Bengt Winblad; Nikolaos Sfikas; Linda Mancione; Yunsheng He; Sibel Tekin; Alistair Burns; Jeffrey Cummings; Teodoro del Ser; Domenico Inzitari; Jean-Marc Orgogozo; Heinrich Sauer; Philip Scheltens; Elio Scarpini; Nathan Herrmann; Martin Farlow; Steven Potkin; H Cecil Charles; Nick C Fox; Roger Lane
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

Review 10.  Cholinesterase inhibitors for Alzheimer's disease.

Authors:  J Birks
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
View more
  1 in total

Review 1.  Evidence Quality Assessment of Tai Chi Exercise Intervention in Cognitive Impairment: An Overview of Systematic Review and Meta-Analysis.

Authors:  Hongshuo Shi; Chengda Dong; Hui Chang; Lujie Cui; Mingyue Xia; Wenwen Li; Di Wu; Baoqi Yu; Guomin Si; Tiantian Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-25       Impact factor: 2.650
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.